Want to see MRKR full AI Analyst Report?
Mt-401-Ots
Mds, Acute Myeloid Leukemia, In Relapse
Phase I
Recruiting
Safety of MT-401-OTS in Patients With Relapsed AML or MDS
Aug 07, 2024
―
Mt-601
Non Hodgkin Lymphoma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Adult, Non-Hodgkin Lymphoma, Refractory, Non-Hodgkin Lymphoma, Relapsed, Hodgkin Lymphoma, Adult, Hodgkin's Lymphoma, Relapsed, Adult
Phase I
Recruiting
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
Mar 14, 2023
―
Mt-401
Acute Myeloid Leukemia, Stem Cell Transplantation
Phase II
Completed
Efficacy of MT-401 in Patients With AML Following Stem Cell Transplant
Jul 30, 2020
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Marker Therapeutics Inc (MRKR) have in its pipeline
MRKR is currently developing the following drugs: Mt-401-Ots, Mt-601, Mt-401. These drug candidates are in various stages of clinical development as the company works toward FDA approval.